FDA Inspection
Deborah Heart & Lung Center IRBDeborah Heart & Lung Center IRB – FDA Inspection, Jul 26, 2021
Record Details
This FDA Inspection record concerns Deborah Heart & Lung Center IRB, with an inspection on July 26, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- July 26, 2021
- Product Type
- Drugs
View Company Profile
ID · d919f38a-e59f-4f6a-b337-ae99785b79e9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1147392
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
4- 21 CFR 56.108(c)Members present for review
- 21 CFR 56.115(a)(2)Minutes of IRB meetings
- 21 CFR 56.108(b)(2)Prompt reporting of noncompliance
- 21 CFR 56.107(f)Invited individual allowed to vote with IRB
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Deborah Heart & Lung Center IRB
2| Date | Classification | Office | Project area |
|---|---|---|---|
| March 30, 2016 | VAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
| October 7, 2011 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Deborah Heart & Lung Center IRB
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.